DOCPHARMA
ActiveSummary
DOCPHARMA has been active since 1999 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €36.6m and a net result of €581,444. Equity remains stable across the filed fiscal years (±1.4% per year). The computed 12-month bankruptcy probability is 0.3% (very low).
Group and network
Holdings and subsidiaries
1 holdingHoldings 1
-
99.99%
According to the 2025 annual accounts of DOCPHARMA and those of the other companies, the acts in the Belgian Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Companies Code and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
3 current directorsThe board mandates are listed below; here you explore them as a network.